Articles
Latest Articles
Commentaries
Deals
Distillery
Emerging Companies
Finance
Politics, Policy & Law
Product Development
Regulation
Targets & Mechanisms
Tools & Techniques
Current Editions
Search Archives
BCIQ
Company Profiles
Target Profiles
Product Profiles
Conferences
China Healthcare Summit
Bio€quity Europe
White Papers
Free Trial
/
Subscribe
Sign In
more_vert
Biocentury
Company Profiles
Target Profiles
Product Profiles
Free Trial Information
Export Pdf
Overview
Articles
BioCentury
|
May 30, 2011
Finance
Rearranging the chairs
...Chiang nominated Frank Litvak. Litvak is the former chairman and CEO of medical device company
Conor Medsystems Inc.
...
Read More
BioCentury
|
May 25, 2011
Politics & Policy
Thomas, Litvak in play for CIRM committee chair
...a founding partner of Saybrook Capital, and Litvak is the former chairman and CEO of
Conor Medsystems Inc.
...
Read More
BioCentury
|
Nov 3, 2008
Clinical News
Nevo sirolimus-eluting coronary stent update
...J&J's
Conor Medsystems
LLC and Cordis Corp. units completed enrollment of 388 patients in the international RES-ELUTION...
Read More
BioCentury
|
Aug 11, 2008
Company News
Pervasis board of directors update
...Therapeutics Inc. , Cambridge, Mass. Business: Cardiovascular Appointed: Frank Litvack, former chairman and CEO of
Conor Medsystems
...
Read More
BioCentury
|
Jul 14, 2008
Company News
Angiotech, J&J cardiovascular news
...22, 2007). The patent was challenged in the U.K. in 2005 by Johnson & Johnson’s
Conor Medsystems Inc.
...
Read More
BioCentury
|
Mar 31, 2008
Clinical News
Conor: Trial started
...J&J’s
Conor Medsystems
LLC and Cordis Corp. units began the single-blind, international RES-ELUTION trial in 388 patients...
Read More
BioCentury
|
Sep 24, 2007
Company News
Angiotech, J&J cardiovascular news
...ANP and JNJ's
Conor Medsystems Inc.
subsidiary settled all outstanding patent litigation regarding Conor's CoStar paclitaxel-eluting stent and...
Read More
BioCentury
|
Jul 16, 2007
Company News
Orexigen management update
...as VP and general counsel, formerly associate general counsel, corporate at Johnson & Johnson 's
Conor Medsystems
...
Read More
BioCentury
|
May 14, 2007
Clinical News
CoStar: Development discontinued
...JNJ's
Conor Medsystems
LLC unit discontinued development of CoStar after the stent missed the primary endpoint of...
Read More
BioCentury
|
Mar 19, 2007
Company News
Angiotech, Boston Scientific, J&J cardiovascular news
...The European Patent Office rejected an attempt by JNJ subsidiary
Conor Medsystems Inc.
to appeal the office's earlier...
Read More
Items per page:
10
1 - 10 of 27
BioCentury
|
May 30, 2011
Finance
Rearranging the chairs
...Chiang nominated Frank Litvak. Litvak is the former chairman and CEO of medical device company
Conor Medsystems Inc.
...
Read More
BioCentury
|
May 25, 2011
Politics & Policy
Thomas, Litvak in play for CIRM committee chair
...a founding partner of Saybrook Capital, and Litvak is the former chairman and CEO of
Conor Medsystems Inc.
...
Read More
BioCentury
|
Nov 3, 2008
Clinical News
Nevo sirolimus-eluting coronary stent update
...J&J's
Conor Medsystems
LLC and Cordis Corp. units completed enrollment of 388 patients in the international RES-ELUTION...
Read More
BioCentury
|
Aug 11, 2008
Company News
Pervasis board of directors update
...Therapeutics Inc. , Cambridge, Mass. Business: Cardiovascular Appointed: Frank Litvack, former chairman and CEO of
Conor Medsystems
...
Read More
BioCentury
|
Jul 14, 2008
Company News
Angiotech, J&J cardiovascular news
...22, 2007). The patent was challenged in the U.K. in 2005 by Johnson & Johnson’s
Conor Medsystems Inc.
...
Read More
BioCentury
|
Mar 31, 2008
Clinical News
Conor: Trial started
...J&J’s
Conor Medsystems
LLC and Cordis Corp. units began the single-blind, international RES-ELUTION trial in 388 patients...
Read More
BioCentury
|
Sep 24, 2007
Company News
Angiotech, J&J cardiovascular news
...ANP and JNJ's
Conor Medsystems Inc.
subsidiary settled all outstanding patent litigation regarding Conor's CoStar paclitaxel-eluting stent and...
Read More
BioCentury
|
Jul 16, 2007
Company News
Orexigen management update
...as VP and general counsel, formerly associate general counsel, corporate at Johnson & Johnson 's
Conor Medsystems
...
Read More
BioCentury
|
May 14, 2007
Clinical News
CoStar: Development discontinued
...JNJ's
Conor Medsystems
LLC unit discontinued development of CoStar after the stent missed the primary endpoint of...
Read More
BioCentury
|
Mar 19, 2007
Company News
Angiotech, Boston Scientific, J&J cardiovascular news
...The European Patent Office rejected an attempt by JNJ subsidiary
Conor Medsystems Inc.
to appeal the office's earlier...
Read More
Items per page:
10
1 - 10 of 27
Previous page
Next page